Votumumab
|
WikiDoc Resources for Votumumab |
|
Articles |
|---|
|
Most recent articles on Votumumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Votumumab at Clinical Trials.gov Clinical Trials on Votumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Votumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Votumumab Discussion groups on Votumumab Directions to Hospitals Treating Votumumab Risk calculators and risk factors for Votumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Votumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Votumumab (marketed under the brand name HumaSPECT) is a human monoclonal antibody and which it is used to treat cancer.
Template:Humanmonoclonals
Template:WH
Template:WikiDoc Sources